Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Right heart cardiac ultrasound contrast agent for shunts enters U.S. trial
Currently there are no FDA cleared echocardiography contrast agents commercially available for use on the right side of the heart to detect shunts, but a new agent that promises to improve workflow and imaging is about to enter a U.S. trial.
ACC testifies in Washington to get funding for the HEARTS Act amid big cuts to healthcare
ACC President Christopher Kramer, MD, testified before a Congressional subcommittee to ask for federal funding to support a new law aimed at reducing sudden cardiac arrest deaths, and to support NIH research.
FDA clears new device for enabling access to the heart’s surface without an exposed needle
CardioVia's ViaOne technology includes a blunt-tip needle that remains concealed to help interventional cardiologists and electrophysiologists treat cardiac arrhythmias with a reduced risk of perforation or any other complications.
A simple way to ensure more heart patients with severe AS receive the care they need
Sending helpful alerts through email and the electronic health record can make a significant impact on patient care, according to new data presented at ACC.25 and published in Circulation.
Starfish-shaped heart monitors use AI to deliver accurate results
Researchers have taken inspiration from starfish to design an AI-powered wearable device that delivers accurate real-time heart monitoring.

Multidisciplinary quality improvement initiative significantly improves on-time starts for cardiac MRI

Such delays can result in longer patient fasts, extended wait times, and poor synchronization of anesthesia induction, researchers detailed in JACR.

Robert Hendel, MD, Tulane University and former ASNC president, explains the pressing business aspects of nuclear cardiology and why ASNC included business management sessions at its 2023 annual meeting. #ASNC #ASNC23 #ASNC2023

Business considerations in the modern nuclear cardiology practice

Robert Hendel, MD, discussed everything from declining reimbursements in cardiology to prior authorization policies in an exclusive new interview.

Newsweek ranked the 50 best heart hospitals in the world

One-stop cardiology clinic opens, offering same-day CVD diagnoses

The new healthcare facility is the first of its kind, offering same-day cardiac imaging scans, cardiologist consultations and diagnoses.

Impella Heart Pump Abiomed RECOVER IV RCT cardiogenic shock

FDA warns Abiomed about ‘significant violations’ related to its Impella heart pumps

The agency said Abiomed did not seek the necessary approvals for one Impella-related device and was slow to act on certain safety concerns.

Former SCCT president Eric Williamson, MD, FSCCT, vice chair for radiology informatics and AI at Mayo Clinic, presented the session one staffing challenges and provided insights into recruitment and retention strategies for physicians and technologists in the field. #SCCT #SCCT23 #SCCT2023 #cardiovascularbusiness

How to address staffing shortages in cardiac CT

Eric Williamson, MD, a former SCCT president, examined recruitment and retention strategies for physicians and technologists in the field of cardiac CT.

Mobile imaging provider to pay $85M for false claims stemming from alleged referral scheme

The alleged kickback scheme spanned nine years, with Cardiac Imaging Inc. paying physicians "excessive fees" to oversee PET scans, the DOJ said.

Cardiologists at heart of alleged kickback scheme—imaging provider, CEO to pay $85M to settle

The allegations revolve around payments referring cardiologists received to supervise PET scans from March 2014 to May 2023.

Timothy Bateman, MD, co-director, cardiovascular radiologic imaging program, Saint Luke's Mid America Heart Institute, professor of medicine at the University of Missouri-Kansas City School of Medicine, and an ASNC past-president, is one of the authors on the AURORA study. He spoke with Cardiovascular Business about the study and what it is like to work with flurpiridaz.

Flurpiridaz will have a major impact on cardiac PET and nuclear imaging

The new radiotracer flurpiridaz is poised to make a major impact on nuclear cardiology. Timothy Bateman, MD, co-director of the cardiovascular radiologic imaging program at Saint Luke's Mid America Heart Institute, shared details on the tracer in a new interview.

Cardiac Imaging

Right heart cardiac ultrasound contrast agent for shunts enters U.S. trial

ACC testifies in Washington to get funding for the HEARTS Act amid big cuts to healthcare

FDA clears new device for enabling access to the heart’s surface without an exposed needle

A simple way to ensure more heart patients with severe AS receive the care they need

Starfish-shaped heart monitors use AI to deliver accurate results